A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).

被引：0
|
作者：
Li, Zhao
Xu, Peng-Fei
Mao, Wei-Min
Kuang, YuKang
Fan, Hai-Yin
Zou, Bin
Zhu, Jian-Feng
Li, Chao
Cheng, Xiao-Liang
Liu, Xing-Fei
Guo, Changying
机构：
[1] Jiangxi Prov Tumor Hosp, Nanchang, Peoples R China
[2] Nanchang Univ, Jiangxi Prov Tumor Hosp, Med Coll, Nanchang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16038
引用
收藏
页码：E16038 / E16038
页数：1
相关论文
共 50 条
  • [41] Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?
    Jiacong Liu
    Linhai Zhu
    Xuhua Huang
    Zhongjie Lu
    Yanye Wang
    Yuhong Yang
    Jiayue Ye
    Chen Gu
    Wang Lv
    Chong Zhang
    Jian Hu
    Journal of Cancer Research and Clinical Oncology, 150
  • [42] Genomic characteristics in neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    He, Wenwu
    Leng, Xuefeng
    Wang, Kangning
    Mao, Tiaoqin
    Peng, Lin
    Fang, Qiang
    Xiao, Wenguang
    Han, Yongtao
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1105 - 1112
  • [43] Neoadjuvant versus definitive chemoradiation for locally advanced esophageal squamous cell carcinoma
    Post, Carl M.
    Haefner, Matthias F.
    Lin, Chi
    Simone, Charles B., II
    Verma, Vivek
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S625 - S628
  • [44] Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
    Chen, Fei
    Qiu, Lingdong
    Mu, Yushu
    Sun, Shibin
    Yuan, Yulong
    Shang, Pan
    Ji, Bo
    Wang, Qifei
    FRONTIERS IN SURGERY, 2022, 9
  • [45] Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC)
    Dong, Y.
    Luo, J.
    Liu, S.
    Han, H.
    Lin, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S866 - S866
  • [46] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
    Chen, Yueyun
    Ding, Zhen-Yu
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 352 - 352
  • [47] Benefit of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: trial sequential analysis
    Chen, I-Wen
    Yu, Ting-Sian
    Hung, Kuo-Chuan
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (09) : 5905 - 5906
  • [48] Neoadjuvant adebrelimab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: A phase 2 trial
    Li, Zhigang
    Yang, Yang
    Liu, Zhichao
    Li, Chunguang
    Su, Yuchen
    Zhang, Hong
    Liu, Jun
    Zhang, Ming
    Dong, Yun
    Han, Yuchen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 443 - 443
  • [49] Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
    Yang, Guozhen
    Su, Xiaodong
    Yang, Hong
    Luo, Guangyu
    Gao, Chan
    Zheng, Yating
    Xie, Wenzhuan
    Huang, Mengli
    Bei, Ting
    Bai, Yuezong
    Wang, Zhiqiang
    Cai, Peiqiang
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhang, Yijun
    Qu, Chunhua
    Fu, Jianhua
    Liu, Qianwen
    Hu, Yi
    Zhong, Jiudi
    Huang, Yuanheng
    Guo, Qiyu
    Zhang, Xu
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (15)
  • [50] The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma
    Shen, Dijian
    Chen, Qixun
    Wu, Jie
    Li, Jianqiang
    Tao, Kaiyi
    Jiang, Youhua
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (01) : 1 - 10
12345